Fig. 4From: Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodiesProduction and characterization of mAb specific to autocatalytic loop. (a) mAb3F3 specifically binds to the autocatalytic loop. ELISA of mAb3F3 binding to the BSA conjugated Mat-Loop, and not to BSA only. (b) Competition human (Mat-Loop) and mouse loop (Epi-Loop) peptides to mAb3F3 binding on ELISA, coated with BSA conjugated human loop peptide. SC, scrambled sequence did not compete. (c) Modeling of mAb3F3. Red: H-CDR1, Yellow: H-CDR2, Blue: H-CDR3, Green: L-CDR1, Purple: L-CDR2, Gray: L-CDR3. (d) Docking modeling of mAb3F3 to Mat-loop peptides (lowest energy, − 238). Cyan: loop peptide. (e) Amino acids interacting with mAb3F3 in Mat-loop peptide were indicated as cyan. White arrow indicates the activation cleavage site. (f-i) Immunoprecipitation and western blotting for testing specific interaction of mAb3F3 to native Prss14/ST14 in cells. (f) Whole lysates of HEK293T cells transfected with full-length human Prss14 (Mat) and vector (Vec) were reacted with mAb3F3. (g) Whole lysates of HEK293T cells transfected with EGFP-S805A and EGFP was immunoprecipitated with mAb3F3 (h) Immunoprecipitation of MCF7. (i) Immunoprecipitation of 4 T1. (j) Flow cytometry of human Prss14/ST14 expressing HEK293T cells. Mat-Loop and Epi-Sc were used for competition. (k) Flow cytometry with CHO-S cells transiently transfected with CD8 or full length Prss14/ST14Back to article page